Evidence obtained from experiments with rats and mice is presented suggesting that the naturally occurring amino acids putreanine and N8-(2-carboxyethyl)spermidine, and most probably also related compounds deriving from the polyamines spermidine and spermine by oxidative metabolism, are formed within two anatomical compartments. In the first step polyamines are converted into aldehydes by serum spermine oxidase in the circulation. A certain portion of these aldehydes can be taken up by liver and other organs and transformed by aldehyde dehydrogenase into the corresponding amino acids. Putreanine is not only derived from spermidine, but can also be formed from N8-(2-carboxyethyl)spermidine by oxidative deamination, catalysed by serum spermine oxidase, and subsequent spontaneous elimination of acrolein.
In the course of the last decade a number of amino acids have been detected in tissues and urine that are obviously oxidative metabolites of spermidine and spermine. Putreanine [N-(4-aminobutyl)-3-aminopropionic acid; Nl-(2-carboxyethyl)-1,4-diaminobutanel was first detected in rat brain (Kakimoto et al., 1969; Shiba & Kaneko, 1969) and was subsequently found in human (Perry et al., 1972; Kremzner, 1973) and monkey brain (Kremzner & Sturman, 1979) and in various organs of rat and rabbit (Nakajima & Matsuoka, 1971; Nakajima, 1973) . Furthermore it is formed in mouse neuroblastoma cell cultures (Kremzner, 1973; Kremzner et al., 1975) . Putreanine, isoputreanine [N-(3-aminopropyl)-4-aminobutyric acid; Nl-(3-carboxypropyl)-1,3-diaminopropanel and the spermine derivatives N8-(2-carboxyethyl)spermidine [N'-(3-aminopropyl)-N4-(2-carboxyethyl)-1,4-diaminobutanel and spermic acid [N'N4-bis-(2-carboxyethyl)-1,4-diaminobutanel are constituents of rat urine (Noto et al., 1978; Asatoor, 1979) . The latter compound was also found in bovine brain (Imaoka & Matsuoka, 1974) .
The intraventricular injection of labelled putrescine or spermidine led to the detection of labelled putreanine in brain; intraperitoneal injections resulted in the occurrence of radioactive putreanine and isoputreanine in liver and urine (Nakajima, 1973; Noto et al., 1978) . Intraperitoneal [ '4C ]spermine Vol. 200 injections produced the corresponding labelled mono-and di-carboxylic acids, which were found in the urine (Noto et al., 1978) .
Although the precursor-product relationships are clear, nothing is known of the enzymes involved in the metabolic transformations of spermidine and spermine, which lead to the formation of their amino acid derivatives. Several authors (Kakimoto et al., 1969; Nakajima, 1973) have speculated that an oxidase analogous to serum spermine oxidase (Blaschko, 1962) , which can form a monoaldehyde from spermidine and a mono-or di-aldehyde from spermine, may catalyse the first step. These aldehydes spontaneously eliminate acrolein . But the corresponding amino acids could be formed from these aldehydes by the action of an aldehyde dehydrogenase, before acrolein elimination took place (Fig. 1 ). However, a tissue oxidase having these properties has not been demonstrated (Morgan, 1980) .
In the present paper we furnish evidence that the formation of the acidic polyamine derivatives is the result of metabolic events taking place in two different anatomical compartments; the first step, namely oxidative deamination of the polyamines, occurs in the circulation; some of the aldehydes thus Materials and methods Determination of polyamines and their acidic metabolites (a) Liquid chromatography. For the determination of the polyamines and of N8-(2-carboxyethyl)spermine a previously published method was used that in essence separates on a reversed-phase column the ion pairs formed between the amines and octane sulphonate (Seiler & Knodgen, 1980) . For quantification the reaction of primary amines with o-phthalaldehyde and 2-mercaptoethanol (Roth & Hampai, 1973) was utilized with continuous monitoring of fluorescence at 455 nm (fluorescence excitation at 345 nm).
Putreanine was determined by using [tetra- methylene-1,4-14C]spermidine as precursor. Samples were separated with a Durrum amino acid analyser by using the elution program designed by Folk et al. (1980) . Fractions were collected every 1.5min and radioactivity was counted by liquid-scintillation spectrometry. Calculations of amount were made on the assumption that the specific radioactivities of putreanine and of its precursor spermidine were identical.
(b) Dansylation procedure. Reaction with dansyl
(5-dimethylaminonaphthalene-1-sulphonyl) chloride was carried out as previously described (Seiler, 1970 (Seiler, , 1975 solution of dimethylamine, the dansyl derivatives were extracted from a reaction mixture, consisting of 0.3 ml of aqueous phase and 0.9 ml of acetone, by addition of 2 ml of ethyl acetate and after thorough mixing with 1 ml of toluene. Samples (3.5 ml) of the organic layer were applied on small alumina columns. These were prepared by introducing 400mg of alumina (basic, cationotropic; activity grade I; Woelm, Eschwege, Germany) into 1 ml pipette tips, which had a cotton wool plug at the constricted end. To elute dansylated polyamines and dansylated acetylpolyamines the columns were washed with 3 ml of methanol. Elution of bisdansylputreanine and trisdansyl-N8-(2-carboxyethyl)spermidine was achieved with 3 ml of methanol/conc. NH3 (4: 1, v/v). (Seiler & Knodgen, 1979) .
Determination ofserum spermine oxidase activity The activity of this enzyme in calf serum was determined by using spermine tetrahydrochloride or spermidine trihydrochloride as substrates, and measurement of peroxide formation by the method of Snyder & Hendley (1968) (Schuler, 1952) and was shown in the present work also to be an inhibitor of serum spermine oxidase. Marsilid inhibits both monoamine oxidase (Zeller & Barsky, 1952) and serum spermine oxidase (Tabor et al., 1954) . The inhibition of the latter enzyme by 3-hydroxybenzyloxyamine was reported by Gaugas (1981) . Pargyline is both an inhibitor of monoamine oxidase (Taylor et al., 1960) and of aldehyde dehydrogenase(s) (Shirota et al., 1979; Lebsack & Anderson, 1979 . On the foriatibn of amino acids deriving from spermidine and spermine esters. Further identification was achieved by chromatographic comparison of the dansyl derivatives, using the procedures described in detail in the Materials and methods section. The thin-layer chromatogram of the dansylated liver extract of a spermine-treated mouse showed a massive spot co-migrating with authentic trisdansyl-N8-(2-carboxyethyl)spermidine. A peak corresponding with bisdansyl-putreanine could be demonstrated in the liver extract of a spermidine-treated animal. The chromatographic patterns of the liver extracts of control and putrescine-treated animals were identical.
Our high-pressure-liquid-chromatographic procedure (Seiler & Knodgen, 1980) allows the determination of N8-(2-carboxyethyl)spermidine only in the absence of N'-acetylspermidine and vice versa; putreanine is eluted in a region that overlaps with normal liver constituents. The dansylation technique described in the Materials and methods section is suitable for the determination of both putreanine and N8-(2-carboxyethyl)spermidine. Its sensitivity is comparable with that of the high-pressure-liquidchromatographic method. Both procedures allow the measurement of less than 200pmol of these amino acids. Time and dose relationships of putreanine and N8-(2-carboxyethyl)spermidineformation in vivo Amounts of [ '4Clspermidine trihydrochloride and spermine tetrahydrochloride ranging from 0.01 mmol/kg body wt. to 0.5 mmol/kg body wt.
(1 mmol of spermine tetrahydrochloride/kg body wt. was lethal within 30min) were administered intraperitoneally to mice. At various times after administration animals were killed and the livers and other organs were extracted with 0.2M-HCO04, and the extracts were separated as described in the Materials and methods section. The high-pressureliquid-chromatographic method (Seiler & Knddgen, 1980) could be used for N8-(2-carboxyethyl)-spermidine measurement in liver and other tissues, since the absence of significant amounts of N'-acetylspermidine had already been established. This was achieved by showing the stability of the measured compound against hydrolysis with 6 MHCl. Authentic N8-(2-carboxyethyl)spermidine was used as standard.
There was a well-defined dose and time relationship between the amount of intraperitoneally administered polyamines and the appearance of putreanine and N8-(2-carboxyethyl)spermidine in liver respectively, as shown in Table 1 . Measurable amounts of these compounds were seen at 30min after a dose of 0.01mmol of spermidine or spermine/kg body wt.; a massive increase of these amino acids was observed with increasing polyamine doses. Even at toxic doses (>0.1mmol/kg body wt.), the transformation process was not saturated. Concentrations of putreanine were usually higher at 30 min than at 2 h, whereas N8-(2-carboxyethyl)-spermidine peaked about 2 h after spermine administration.
At 24 h after intraperitoneal administration of 0.1 mmol of the precursor amines/kg body wt., significant amounts of the polyamine-derived amino acids were still observed. However, 2h after an oral dose of 0.5 mmol of spermine tetrahydrochloride/kg The distribution of N8-(2-carboxyethyl)spermidine was estimated in various mouse organs 2 h after an intraperitoneal dose of 0.5 mmol of spermine tetrahydrochloride/kg body wt. Highest concentrations were found in liver (up to 645 nmol/ g) and kidney (494 nmol/g). Lower concentrations were found in small intestine (53 nmol/g) and skeletal muscle (20 nmol/g). All other organs and blood contained less than lOnmol of N8-(2-carboxyethyl)spermidine/g.
The distribution of putreanine in male Cox mice was estimated in these organs after an injection of 1.0 mmol of spermidine/kg body wt. Highest amounts of putreanine were found in liver (109.4 nmol/g) and kidney (7.6nmol/g). All other tissues either contained very small amounts of putreanine or the concentration was not detectable with the procedure employed.
Effects of some oxidase inhibitors on the formation ofputreanine and N8-(2-carboxyethyl)spermidine in vivo Mice were treated with intraperitoneal doses of 100mg or 200mg of aminoguanidine sulphate or pargyline hydrochloride/kg body wt. After 3.5 h they received either 1.0 mmol of spermidine trihydrochloride/kg body wt. or 0.5 mmol of spermine tetrahydrochloride/kg body wt. intraperitoneally. After another 2 h the animals wee killed by decapitation, and the liver concentrations of putreanine and N8-(2-carboxyethyl)spermidine were determined. As can be seen in Fig. 2 (c) pretreatment with 100mg of aminoguanidine sulphate/kg body wt. produced a nearly complete block to N8-(2-carboxyethyl)-spermidine formation, and approximately the same effect was achieved with 200mg of pargyline/kg body wt. (Fig. 2d) . With 100mg of pargyline/kg body wt., inhibition was approx. 500/o. Identical results were obtained for the formation of putreanine from spermidine.
Formation of putreanine from N8-(2-carboxyethyl)-spermidine
The theoretical possibility existed that putreanine was formed not only by oxidative deamination of spermidine, but also from N8-(2-carboxyethyl)-spermidine.
The reaction sequence (Fig. 3 ) was presumed to be analogous to that of spermidine formation from spermine ( Fig. 1), i.e. oxidative deamination by plasma amine oxidase and spontaneous /3-elimination of acrolein.
Incubation of 1 mM-N8-(2-carboxyethyl)spermidine with newborn-calf serum (60ul) in S6rensen phosphate buffer generated putreanine. Its formation was demonstrated by t.l.c. of the dansyl derivatives using preseparation on alumina columns as described in the Materials and methods section. The thin-layer chromatograms demonstrated that the amount of putreanine formed increased as a function of incubation time. A second unidentified compound, though present in lower amounts, was also formed under these reaction conditions.
Formation of N8-(2-carboxyethyospermidine from spermine in vitro
Incubation of 1 mM-spermine tetr'ahydrochloride with lOO,l of Sorensen phosphate biffer and 60,u1 of newborn-calf serum for 30min at 3-70C produced a considerable amount of putrescine and spermidine as shown in Fig. 4(a) . If incubations were performed in the absence of serum with a 1:10 (w/w) homogenate of mouse liver, which had been perfused with 0.9% NaCl solution -before homogenization, spermine concentration-remained unchanged (results not shown (b) newborn-calf serum was added to the incubation mixture containing homogenate of mouse liver, a new peak appeared in the chromatograms in addition to those of spermidine and putrescine (Fig.  4b) . The new peak was identified as N8-(2-carboxyethyl)spermidine by the same methods that were described for the experiments in vivo. (The peak that eluted shortly after spermine is an unknown component of calf serum.)
Under the reaction conditions it appeared that more N8-(2-carboxyethyl)spermidine than spermidine was formed (Fig. 4b) . This shows that N8-(2-carboxyethyl)spermidine can be a major degradation product of spermine under favourable conditions. It could not be established whether spermic acid was formed, since this compound does not give a fluorescent reaction product with ophthalaldehyde, the detector reagent in the highpressure-liquid-chromatographic method.
Qualitatively the same results were observed if calf serum was substituted with mouse serum. However, the amount of N8-(2-carboxyethyl)spermidine formed under these conditions was only about 0.4% of that formed with newborn-calf serum. spermidine by the combined action of rat liver homogenate and newborn-calfserum (b) Reversed-phase liquid-chromatographic separation of the components of the incubation mixture was carried out. The chromatographic procedure is the same as that in Fig. 2 (for details see Seiler & Knodgen, 1980 
Formation ofputreaninefrom spermidine in vitro
To test whether intact liver cells were capable of transforming spermidine into putreanine in the presence of calf serum, incubations in vitro were performed with identical amounts of tissue from the same rat liver. In one series 0.3 mm thick slices were made from pieces of liver of about 5 mm diameter, using the Mcllwain tissue chopper (The Mickle Laboratory Engineering Co., Gomshall, Surrey, U.K.). For the other series, rat liver slices were homogenized with three parts of ice-cold Sorensen phosphate buffer, pH 7.4. The incubation mixtures contained either 900,1 of liver homogenate and lOOul of buffer or 225mg of liver slices suspended in 1000l 1 of phosphate buffer. In both cases lOO,u of spermidine,3HCl solution in phosphate buffer (21.6 mg/5 ml; this corresponds to a final concentration of 1 mM) was used and the reaction was started by addition of 600,1 of calf serum. After incubation at 370C for various intervals with constant shaking the reaction was stopped with 30,1 of conc. HC104. Putreanine formation was determined from a portion of the HC104 extract, using the dansylation procedure (see the Materials and methods section). The results are summarized in Fig.  5 . There was no fundamental difference in the rate of putreanine formation by slices and homogenates.
However the onset of the reaction was faster in the (0) and putreanine formation from spermidine in incubation mixtures containing rat liver homogenate and newborn-calf serum (0) Each point is the mean of two independent experiments. For experimental details see the Materials and methods section.
slices, probably due to a higher initial consumption of 02 in the homogenate by competing reactions. Maximum rates of putreanine formation were, however, practically the same for both types of incubations, namely 670nmol/g of liver per h for slices and 615 nmol/g of liver per h for the homogenates.
Effects ofinhibitors on putreanineformation in vitro
If oxidative deamination of spermidine and spermine is the first step in the transformation of the polyamines into their amino acid analogues, inhibitors of serum spermine oxidase would be expected to influence to the same extent the rate of polyamine deamination and of putreanine or N8-(2-carboxyethyl)spermidine formation. To test this assumption the rate of spermine deamination by newborn-calf serum was determined by measurement of peroxide formation in the presence of inhibitors of serum spermine oxidase. Putreanine formation from spermidine was determined in incubation mixtures that contained both liver homogenate and newborn-calf serum and the same inhibitors. Fig. 6 shows that iproniazid, aminoguanidine sulphate and 3-hydroxybenzyloxyamine affected the two reactions proportionally, although none of these inhibitors is specific for serum spermine oxidase (see the Materials and methods section).
Pargyline had, as expected, no significant influence on spermine or spermidine deamination by calf serum. However, it inhibited putreanine formation by about 400/o at 5 mm concentration.
Discussion
It has been demonstrated by these experiments that no significant amounts of putreanine and N8-(2-carboxyethyl)spermidine are formed from spermidine and spermine respectively, after incubation with rat liver homogenates. Addition of mouse serum and especially of calf serum to the incubation mixture markedly increased the formation of these two amino acids. Calf serum is a rich source of spermine oxidase (Blaschko, 1962) . However, this enzyme alone is not capable of forming putreanine or N8-(2-carboxyethyl)-spermidine from spermidine or spermine.
Since serum in conjunction with either liver tissue slices or homogenates was effective in forming putreanine it is concluded that intact cells are capable of performing this reaction. Inhibitors of spermine oxidase decreased the formation of putreanine from spermidine in a manner proportional to the inhibition of spermine oxidation by serum. Pargyline on the other hand did not inhibit spermine oxidation by serum, but decreased the formation of N8-(2-carboxyethyl)spermidine in the complete system. Pargyline is known to inhibit aldehyde dehydrogenase (Shirota et al., 1979; Lebsack & Anderson, 1979) , in addition to being a potent inhibitor of monoamine oxidase.
We conclude that the transformation of spermine into N8-(2-carboxyethyl)spermidine and of spermidine into putreanine occurs in two steps that take place in two different anatomical compartments; oxidation to the aldehydes is catalysed by spermine oxidase within the circulation; some of the aldehydes are then transferred into the tissues where they are subjected to further oxidation by an aldehyde dehydrogenase to their corresponding amino acids. The reactions are formulated in Fig. 1 . Although it has not been experimentally demonstrated, one has to assume that formation of spermic acid follows the 1981 same scheme. In this case, however, two alternative reaction sequences may exist. The dialdehyde may be formed in the circulation, which then is further oxidised to spermic acid within the tissues. As shown in the present work, N8-(2-carboxyethyl)spermidine is not only formed in excess from spermine, but it is also a substrate of spermine oxidase. When entering the circulation from the tissue, N8-(2-carboxyethyl)-spermidine could be transformed into the monoaldehyde. This could either lose an acrolein moiety and thus form putreanine (Fig. 3) , or alternatively it could re-enter the tissue and be transformed into spermic acid. It is evident that the formation of putreanine from N8-(2-carboxyethyl)spermidine is completely analogous to the formation of spermidine from spermine via the monoaldehyde and spontaneous f-elimination of acrolein . It is known that incubation of labelled spermidine with rat brain results in the formation of radioactive putreanine (Nakajima, 1973 ). This finding is not an argument against the present notion of transformation of the polyamines into their amino acid analogues within two compartments. Since rat serum contains spermine oxidase activity (Blaschko, 1962) the amount of blood remaining in organs that are not perfused before homogenization is sufficiently high so as to catalyse the first step of the reaction sequence. It has been clearly shown in the present work that rat liver, if perfused before homogenization, is not capable of forming significant amounts of putreanine or N8-(2-carboxyethyl)-spermidine in the absence of plasma.
It must be presumed that the oxidative deamination of the polyamines to the corresponding amino acids is not the only case of a reaction sequence in which subsequent steps take place in two different anatomical compartments. The oxidative deamination of methylamine is almost certainly another example. It was shown (Werner & Seiler, 1963 ) that inhibitors of both monoamine oxidase and diamine oxidase were effective in decreasing the rate of 14C02 formation from labelled methylamine in vivo. Highly potent inhibitors of monoamine oxidase, such as pargyline and tranylcypromine were, however, less effective than the compounds with a hydrazine moiety. In vitro, neither mouse nor rat organs were capable of oxidizing methylamine effectively. Beef liver which contains serum spermine oxidase due to residual blood, however, was effective, and with this enzyme source the same inhibitor spectrum was found as in the in vivo experiments with mice. These results can be explained without contradiction of the assumption of metabolism in two-compartments.
The observed tissue concentrations of N8-(2-carboxyethyl)spermidine, i.e. high concentrations in liver and kidney, and low concentrations in most Vol. 200 other organs after intraperitoneal administration of spermine is in agreement with a first-pass metabolism in liver and an effective urinary excretion of the spermine and spermidine derived amino acids. A similar distribution pattern was observed with labelled spermidine as a precursor (Nakajima, 1973) .
Endogenous putreanine concentrations are higher in brain than in liver (Nakajima & Matsuoka, 1971) . Since intraventricular [(4C]spermidine injections produced significant amounts of labelled putreanine in the brain one can assume that brain putreanine is formed from spermidine that is directly released from brain cells into the circulation. The effective uptake of the aldehyde by brain cells from the extensive brain capillary system is to be expected. A second possibility is that the polyamines leave the brain via the cerebrospinal fluid. The presence of putrescine, spermidine and also of small amounts of spermine in the cerebrospinal fluid is well established and it has been shown that enhanced polyamine formation in brain tumours is reflected in increased cerebrospinal-fluid polyamine concentrations (Marton et al., 1974) . Whether cerebrospinal fluid contains significant spermine oxidase activity to account for the transformation of the polyamines into the corresponding aldehydes is presently not known.
The fact that putreanine was not detected in Rhesus-monkey brain before birth (Kremzner & Sturman, 1979 ) is probably best explained by the limited capacity of the brain for spermidine and spermine formation due to low S-adenosylmethionine decarboxylase activity in early brain development, at a time of high polyamine demand; as a consequence of this phenomenon only a limited amount of polyamine degradation would be predicted along a pathway that causes irreversible losses of polyamines.
The physiological role of the transformation of polyamines into amino acids in a reaction sequence that comprises two different anatomical compartments is speculative at present. Most probably it has no function in the control of intracellular polyamine concentrations. It is more likely that intracellular polyamine concentrations are regulated by the control of the rate of biosynthesis and by a degradation sequence that comprises acetylation and oxidative degradation of N1-monoacetylspermidine by polyamine oxidase and alternatively excretion of the acetyl derivatives (Seiler, 1981; Bolkenius & Seiler, 1981) .
Since an enzyme of the circulation is involved it is suggested that the formation of amino acids from spermidine and spermine is part of the inactivation system that keeps extracellular polyamine concentrations low, thus avoiding toxicity . Both exogenous (alimentary) poly-amines and polyamines of intracellular origin could be physiological substrates of the reaction sequence.
